Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer - BeOne

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

BeOne Study ID

BGB-A317-206

ClinicalTrials.gov ID

NCT03432598

China Drug Trials ID

CTR20170361

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents